21 Sep 2021
One of the many features provided by global B2B e-commerce platform Madeinindonesia.com is Invoice Financing. Its slogan says “Invoice Financing, Get Capital from Your Unpaid Invoices”.
Invoice Financing is a form of working capital for growing small and medium enterprises (SMEs) that do business with large companies like state-owned enterprises, public listed companies, multinational corporations and government agencies.
The invoices from SMEs serve as collateral for loan applications and getting funded by Lenders. The incoming invoice payments to be paid by Borrowers' clients, Payers, will be used to repay the loans.
The followings are some of the benefits of this invoice financing:
- Zero collateral required
- Cheapest rates
- Easy to apply
- Seven working days approval/disbursement after verification process
- Rp 500 million to Rp 2 billion (for large orders please contact us)
- Flexible terms - choose the invoice you want to finance
- End-to-end export/fulfilment support
- Unlock the capital trapped in unpaid invoices
- Funds to capitalize on new business opportunities
- Flexibility to finance invoices as and when you need
- Short-term capital injection or as a top up to bank financing
So, in brief, with this Invoice Financing, you can enhance your business cashflow and make your assets work harder for you.
How does it work? How the Indonesia wholesale B2B marketplace, Madeinindonesia.com, will process it?
- Get a work order: Potential Borrower is in the process of finishing a job, has finished a job, or has sold products to the client
- Apply: Then submit a copy of the invoice to be financed
- Document checking: We analyze, select and approve loan applications
- Repayment: When the invoice is due, the Payer makes payment for the invoice and the Borrower uses the funds to repay the loan. Lenders will receive the loan repayment which includes principal and interest
The following is a table on Grade, Rates and Risk of Invoice financing
GRADE
|
RATES (PER ANNUM)
|
RISK
|
A+
|
10%
|
Very Low Risk
|
A
|
12%-13%
|
Low Risk
|
B
|
13% - 15%
|
Medium Risk
|
C
|
15% - 17%
|
High Risk
|